Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-07-13

Clinical Trial Update: Effect of in Vitro Blocking the Common Beta Chain on Cell Viability in Asthma

View source ↗

Summary

This trial update reports an in vitro study evaluating blocking the common beta chain and its effect on cell viability in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Asthma | Status: COMPLETED